Matthijs Blokhuis
Managing Director & Chief Executive Officer @ Noaber
Nijmegen, The Netherlands
Matthijs Blokhuis is a seed investor at Noaber in Nijmegen focused on Medical and Software. Matthijs Blokhuis is the Managing Director at Noaber Foundation. He attended Utrecht University.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 67%
Last updated:
For AI agents: llms.txt
Industries Matthijs Blokhuis invests in
Stages Matthijs Blokhuis invests in
Countries Matthijs Blokhuis invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Medical 2 (67%)
- Software 2 (67%)
- Health Care 2 (67%)
- Hospital 1 (33%)
- Analytics 1 (33%)
Stage
- Seed 1 (33%)
- Series A 1 (33%)
- Series B 1 (33%)
Country
- The Netherlands 2 (67%)
- United States 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Syntilio is the only solution that provides a 360-degree view of the patient and the ability to reach out to their whole care network via an extensive suite of follow-up and communication channels. | Seed / Apr 19, 2023 | ||
| NewCompliance drives value in healthcare through modern, interoperable IT platforms that reshape information. | $3M / Series A / Nov 19, 2019 | ||
| Ambient Clinical Analytics is the creator of a software platform designed for data assimilation, communication and analytics. It is based on decision support tools initially deployed in the intensive care unit (ICU) or emergency department of hospitals. Our software consists of algorithms that mine data from electronic medical records (EMR). Itthen presents that data to the physicians and nurses so they may facilitate real-time clinical decision making and care delivery. These products are positioned as add on applications that are designed to easily integrate with the current major EMR providers. | $1.5M / Series B / Jun 19, 2018 |
Co-Investors
About Noaber
Noaber Ventures invests in initiatives that bring social transformations using information technology.
Noaber Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Matthijs Blokhuis
Managing Director & Chief Executive Officer
|
|||
|
Mineke Baan-Pas
Co-Founder & Board Member
|
|||
|
Paul Baan
Co-Founder & Strategic Advisor
|
|||
Tim Dolman
Investment Manager
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Matthijs Blokhuis invest in?
Matthijs Blokhuis invests primarily in Medical, Software and Health Care startups, most often at Seed and Series A stage. Most of the 3 investments tracked by Shizune back companies in The Netherlands. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Matthijs Blokhuis?
Public channels for Matthijs Blokhuis include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Matthijs Blokhuis last invest?
The most recent investment recorded for Matthijs Blokhuis closed in Apr 2023. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
